On April 30th the Gynecological Cancer InterGroup’s (GCIG) Spring Meeting commences, where participants from various international gynaecologic cancer research groups will discuss the latest developments in gynaecologic cancer clinical trials.
Assoc Prof Alison Brand AM
GCIG works to optimise outcomes for women with gynaecological cancer, through the promotion and facilitation of clinical trials. The international research organisation meet twice a year to foster collaborative academic clinical trials across multi-member countries.
ANZGOG is a significant collaborator internationally in gynaecological cancer clinical trials development and operation. It regularly has a large number of members participating at the GCIG and on its various committees.
ANZGOG’s Appointments to the GCIG
ANZGOG Director and past Chair Assoc Prof Alison Brand AM has been appointed Chair-Elect to the GCIG, following in the footsteps of another former ANZGOG Chair – Prof Michael Quinn AM – who also served as GCIG Chair.
GCIG Chair appointments are for two years. Alison Brand AM has served on the GCIG Executive for a number of years and was nominated by ANZGOG as their organisation representative.
In addition, Prof Linda Mileshkin has been appointed Co-Chair/Chair-elect of the Endometrial Committee of GCIG. Prof Mileshkin is also an ANZGOG Director and Chair of the newly formed ANZGOG Endometrial Cancer Research Initiative (EDEN Initiative).
ANZGOG’s International Collaborations
Both GCIG appointments, in addition to several ANZGOG members who are currently committee and council members of International Gynaecological Cancer Society (IGCS), demonstrate ANZGOG’s growing reputation and leadership in the global gynaecological cancer research space.
ANZGOG joined GCIG as one of the founding members in 2001, and since then has continued to foster a strong partnerships to improve treatment outcomes for gynaecological cancer patients.
“We worked hard to establish ANZGOG, and we were very pleased when we could finally advise GCIG about the formation of ANZGOG. One of the major goals was to provide opportunities to ANZ investigators to develop new concepts, and where appropriate take them to GCIG”, Prof Danny Rischin, Inaugural Chair – ANZGOG’s Research Advisory Committee.
Since forming a relationship with GCIG, ANZGOG’s international collaborations have continued to be the key to its success in improving life for women with a gynaecological cancer.
